Inhibitors of soluble adenylate cyclase

US7449459B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Bernd Buchmann · Hohen Neuendorf, DE
• Dirk Kosemund · Berlin, DE
• Bernd Menzenbach · Jena, DE
• Martin Fritsch · Berlin, DE

Key dates

• Filing date: Mar 23, 2007
• Grant date: Nov 11, 2008
• Expiry date: Mar 23, 2027

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D209/42
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to compounds of general formula I as well as the production and use thereof as a medication.